Cargando…
Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells
Prolactin-releasing peptide (PrRP), a natural ligand for the GPR10 receptor, is a neuropeptide with anorexigenic and antidiabetic properties. Due to its role in the regulation of food intake, PrRP is a potential drug for obesity treatment and associated type 2 diabetes mellitus (T2DM). Recently, the...
Autores principales: | Zmeškalová, Anna, Popelová, Andrea, Exnerová, Aneta, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503370/ https://www.ncbi.nlm.nih.gov/pubmed/32882929 http://dx.doi.org/10.3390/ijms21176343 |
Ejemplares similares
-
Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
por: Pražienková, Veronika, et al.
Publicado: (2019) -
Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity
por: Pražienková, Veronika, et al.
Publicado: (2017) -
Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models
por: Mráziková, Lucia, et al.
Publicado: (2021) -
Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study
por: Karnošová, Alena, et al.
Publicado: (2021) -
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study
por: Mikulášková, Barbora, et al.
Publicado: (2018)